Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis

<div><b>Forest plots of relative risk in SR rate.</b> (a) SR at month 6; (b) SR at month 12. CI: confidence interval; M-H: Mantel-Haenszel; RR: relative risk.</div>

BioMed Research International

fig5

Figure 5

Figure 5: Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis 

Figure 5 | Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis 